Cerca | Ayema

ha aggiunto un file Altre informazioni

2023-09-26 01:57:17 -

Dacomitinib in Non-Small Cell Lung Cancer (NSCLC): A Breakthrough Targeted Therapy

Dacomitinib, a potent tyrosine kinase inhibitor (TKI), has emerged as a breakthrough therapy in the field of non-small cell lung cancer (NSCLC) treatment. This article delves into the specific aspects of Dacomitinib in the context of NSCLC, including its mechanism of action, clinical efficacy, potential side effects, and future directions in research and treatment....

0 Commenti 0 condivisioni 2102 Views 0 Anteprima